Woo-Jin Song

Prof. Woo-Jin Song

Department of Veterinary Internal Medicine, College of Veterinary Medicine, Jeju National University, Jeju 63243, Korea
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
WSWoo-Jin Song
Woo-Jin Song
QLQiang Li
Qiang Li
MRMin-Ok Ryu
Min-Ok Ryu
JAJin-Ok Ahn
Jin-Ok Ahn
DBDong Ha Bhang
Dong Ha Bhang
HYHwa-Young Youn
Hwa-Young Youn
Previous studies have revealed that mesenchymal stem cells (MSCs) alleviate inflammatory bowel disease (IBD) by modulating inflammatory cytokines in the inflamed intestine. However, the mechanisms underlying these effects are not completely understood. We sought to investigate the therapeutic effects of human adipose tissue-derived (hAT)-MSCs in an IBD mouse model and to explore the mechanisms of the regulation of inflammation. Dextran sulfate sodium-induced colitis mice were infused with hAT-MSCs intraperitoneally and colon tissues were collected on day 10. hAT-MSCs were shown to induce the expression of M2 macrophage markers and to regulate the expression of pro- and anti-inflammatory cytokines in the colon. Quantitative real time-PCR analyses demonstrated that less than 20 hAT-MSCs, 0.001% of all intraperitoneally injected hAT-MSCs, were detected in the inflamed colon. To investigate the effects of hAT-MSC-secreted factors in vitro, transwell co-culture system was used, demonstrating that tumour necrosis factor-α-induced gene/protein 6 (TSG-6) released by hAT-MSCs induces M2 macrophages. In vivo, hAT-MSCs transfected with TSG-6 small interfering RNA, administered intraperitoneally, were not able to induce M2 macrophage phenotype switch in the inflamed colon and had no significant effects on IBD severity. In conclusion, hAT-MSC-produced TSG-6 can ameliorate IBD by inducing M2 macrophage switch in mice.

30 January 2021 in Anticancer Research
Verified
Journal Article
Closed access
PDF file
KLKyung-Mi Lee
Kyung-Mi Lee
JAJu-Hyun An
Ju-Hyun An
SYSe-Jin Yang
Se-Jin Yang
SPSu-Min Park
Su-Min Park
JLJeong-Hwa Lee
Jeong-Hwa Lee
HYHwa-Young Youn
Hwa-Young Youn
Background/Aim: The purpose of this study was to evaluate the effect of extracellular vesicles derived from canine M1-polarized macrophages (M1EVs) on canine tumor cells, such as D17 (osteosarcoma cells) and LMeC (melanoma cells). Materials and Methods: Protein expression was determined by western blot analysis. Gene expression was determined by RT-qPCR. In addition, cell apoptosis was analyzed by Annexin V/PI staining. Results: In the case of M1EV, the levels of pro-inflammatory cytokines such as TNF-α, IL-6 and IL-1β were increased, and nitrate/nitrite levels were also increased. M1EV induced apoptosis of tumor cells by increasing caspase-3 and caspase-7 activation. In addition, M1EVs decreased expression of CCR4, Foxp3 and CTLA-4 in canine peripheral mononuclear cells cocultured with tumor cells. Conclusion: M1EV could be an effective anti-cancer therapeutic approach in melanoma and osteosarcoma and M1EVs can be used as immunomodulators in the tumor microenvironment for cancer treatment.

1 January 2021 in Journal of Veterinary Science
Verified
Journal Article
Open access
PDF file
SPSeol-Gi Park
Seol-Gi Park
JAJu-Hyun An
Ju-Hyun An
QLQIANG LI
QIANG LI
HCHyung-Kyu Chae
Hyung-Kyu Chae
SPSu-Min Park
Su-Min Park
HYHwa-Young Youn
Hwa-Young Youn
Park SG, et al. J Vet Sci. 2021 Feb;22(2):e16. https://doi.org/10.4142/jvs.2021.22.e16

26 July 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SPSu-Min Park
Su-Min Park
JAJu-Hyun An
Ju-Hyun An
JLJeong-Hwa Lee
Jeong-Hwa Lee
KKKyung-Bo Kim
Kyung-Bo Kim
HCHyung-Kyu Chae
Hyung-Kyu Chae
HYHwa-Young Youn
Hwa-Young Youn
Background Mesenchymal stem/stromal cells (MSCs) are effective therapeutic agents that ameliorate inflammation through paracrine effect; in this regard, extracellular vesicles (EVs) have been frequently studied. To improve the secretion of anti-inflammatory factors from MSCs, preconditioning with hypoxia or hypoxia-mimetic agents has been attempted and the molecular changes in preconditioned MSC-derived EVs explored. In this study, we aimed to investigate the increase of hypoxia-inducible factor 1-alpha (HIF-1 alpha)/cyclooxygenase-2 (COX-2) in deferoxamine (DFO)-preconditioned canine MSC (MSCDFO) and whether these molecular changes were reflected on EVs. Furthermore, we focused on MSCDFO derived EVs (EVDFO) could affect macrophage polarization via the transfer function of EVs. Results In MSCDFO, accumulation of HIF-1 alpha were increased and production of COX-2 were activated. Also, Inside of EVDFO were enriched with COX-2 protein. To evaluate the transferring effect of EVs to macrophage, the canine macrophage cell line, DH82, was treated with EVs after lipopolysaccharide (LPS) stimulation. Polarization changes of DH82 were evaluated with quantitative real-time PCR and immunofluorescence analyses. When LPS-induced DH82 was treated with EVDFO, phosphorylation of signal transducer and transcription3 (p-STAT3), which is one of key factor of inducing M2 phase, expression was increased in DH82. Furthermore, treated with EVDFO in LPS-induced DH82, the expression of M1 markers were reduced, otherwise, M2 surface markers were enhanced. Comparing with EVDFO and EVnon. Conclusion DFO preconditioning in MSCs activated the HIF-1 alpha/COX-2 signaling pathway; Transferring COX-2 through EVDFO could effectively reprogram macrophage into M2 phase by promoting the phosphorylation of STAT3.

1 January 2021 in Journal of Veterinary Medical Science
Verified
Journal Article
Open access
PDF file
SRSung-Yong Rhew
Sung-Yong Rhew
SPSu-Min Park
Su-Min Park
QLQiang Li
Qiang Li
JAJu-Hyun An
Ju-Hyun An
HCHyung-Kyu Chae
Hyung-Kyu Chae
HYHwa-Young Youn
Hwa-Young Youn
Mesenchymal stem cells (MSCs) possess regenerative and immunomodulatory properties and can control the immune dysregulation that leads to β-cell destruction. Stem-cell transplantation could thus manage insulin-dependent diabetes mellitus (IDDM) in dogs. In this pilot study, we aimed to assess canine adipose tissue-derived MSCs (cAT-MSCs) transplantation as a treatment for canine diabetes mellitus. This study included four dogs with over a year of insulin treatment for IDDM, following diagnosis at the Veterinary Medicine Teaching Hospital of Seoul National University. Allogenic cAT-MSCs were infused intravenously three or five times monthly to dogs with IDDM. Blood and urine samples were obtained monthly. General clinical symptoms, including changes in body weight, vitality, appetite, and water intake were assessed. Three of the four owners observed improvement of vitality after stem cell treatment. Two of the four dogs showed improvement in appetite and body weight, polyuria, and polydipsia. C-peptide has increased by about 5–15% in three of the cases, and fructosamine and HbA1c levels have improved in two of the cases. Hyperlipidemia was resolved in two of the dogs, and there was no concurrent bacterial cystitis in any of the dogs. C-peptide secretion and lipid metabolism are associated with diabetic complications. Improvement in these parameters following the treatment suggests that cAT-MSC transplantation in dogs with IDDM might help to improve their insulin secretory capacity and prevent diabetic complications.

30 April 2024 in Journal of Veterinary Clinics
Verified
Journal Article
Open access
PDF file
YJYunhee Joung
Yunhee Joung
HAHyerin Ahn
Hyerin Ahn
JCJeongbae Choi
Jeongbae Choi
YYYoungMin Yun
YoungMin Yun
WSWoo-Jin Song
Woo-Jin Song
Yunhee Joung, Hyerin Ahn, Jeongbae Choi, YoungMin Yun, Woo-Jin Song. J Vet Clin 2024;41:106-11. https://doi.org/10.17555/jvc.2024.41.2.106